# Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients

> **NCT01637493** · PHASE1 · UNKNOWN · sponsor: **Hangzhou Jiuyuan Gene Engineering Co. Ltd.,** · enrollment: 24 (estimated)

## Conditions studied

- Neutropenia

## Interventions

- **DRUG:** Pegfilgrastim
- **DRUG:** Pegfilgrastim
- **DRUG:** Pegfilgrastim
- **DRUG:** Pegfilgrastim

## Key facts

- **NCT ID:** NCT01637493
- **Lead sponsor:** Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2012-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01637493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01637493, "Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01637493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*